Response to: 'Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria: A critical appraisal'

K. Rosén, M. Maurer, H. Hsieh, S. Saini, C. Grattan, A. Gimenéz-Arnau, S. Agarwal, R. Doyle, J. Canvin, A. Kaplan, T. Casale

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)15-16
Number of pages2
JournalBritish Journal of Dermatology
Volume171
Issue number1
DOIs
StatePublished - Jan 1 2014

ASJC Scopus subject areas

  • Dermatology

Cite this

Rosén, K., Maurer, M., Hsieh, H., Saini, S., Grattan, C., Gimenéz-Arnau, A., Agarwal, S., Doyle, R., Canvin, J., Kaplan, A., & Casale, T. (2014). Response to: 'Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria: A critical appraisal'. British Journal of Dermatology, 171(1), 15-16. https://doi.org/10.1111/bjd.13075